Ligand Pharmaceuticals
LGND
#3601
Rank
C$5.02 B
Marketcap
C$255.40
Share price
-1.93%
Change (1 day)
44.61%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Net assets

Net assets on the balance sheet as of September 2025 : C$1.31 Billion

According to Ligand Pharmaceuticals's latest financial reports the company has C$1.31 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Ligand Pharmaceuticals - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$C$1.19 B28.18%
2023-12-31$C$0.92 B14.67%
2022-12-31$C$0.81 B-22.53%
2021-12-31$C$1.04 B15.68%
2020-12-31$C$0.90 B-9.72%
2019-12-31$C$1.00 B31.15%
2018-12-31$C$0.76 B45.17%
2017-12-31$C$0.52 B5.61%
2016-12-31$C$0.49 B29.74%
2015-12-31$C$0.38 B1256.15%
2014-12-31$C$28.32 M-46.37%
2013-12-31$C$52.81 M100.53%
2012-12-31$C$26.33 M216.33%
2011-12-31$C$8.32 M-271.77%
2010-12-31$-C$4.85 Million-223.04%
2009-12-31$C$3.93 M-131.26%
2008-12-31$-C$12.61 Million-143.39%
2007-12-31$C$29.04 M-8.79%
2006-12-31$C$31.84 M-124.77%
2005-12-31$-C$0.13 Billion42.11%
2004-12-31$-C$90.47 Million85.7%
2003-12-31$-C$48.72 Million-141.67%
2002-12-31$C$0.11 B-226.79%
2001-12-31$-C$92.2 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Amgen
AMGN
C$13.28 B 912.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
C$37.03 M-97.18%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$29.25 B 2,128.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
C$71.70 B 5,362.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$128.61 B 9,697.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$32.94 B 2,410.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$25.69 B 1,857.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
C$9.96 B 659.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$109.52 B 8,243.45%๐Ÿ‡บ๐Ÿ‡ธ USA